Rights and permissions
About this article
Cite this article
Entecavir “economically attractive” in US for chronic HBV. Inpharma Wkly. 1630, 4 (2008). https://doi.org/10.2165/00128413-200816300-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816300-00005